\
&
Contact us
\
&
Contact us
This was 6 months ago
LocationBrussels
The “Disaster Resilience Days”, event organised under CERIS (Community for European
Research and Innovation for Security) brings together experts, policymakers, and innovators
from across Europe and beyond to discuss disaster resilience, preparedness, and technological
advancements in crisis response and preparedness.
Key topics include innovation in disaster resilience and preparedness, community engagement,
secure communication, space technologies, and international cooperation, as well as demo
sessions showcasing groundbreaking projects. Additionally, a walking exhibition of projects
provide a platform for professionals to connect and exchange ideas.
For more information on the event, please consult the agenda, and use this link to register for the event.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
